- EPA Earmarks $3 Billion to Replace Lead Pipes Nationwide
- Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits
- No Sign of Bird Flu in Ground Beef, USDA Says
- U.S. Maternal Deaths Declined in 2022
- Economy, Election Spur Rising Anxiety Among Americans in 2024
- Day Care Pick-Up Often Involves Sugary Snacks, Study Finds
- A Third of Young Adults Still Believe ‘Tan Is Healthier’ Myth: Survey
- MRNA Vaccine Fights Deadly Brain Tumor in Small Trial
- AI Won’t Replace ER Doctors Anytime Soon: Study
- Sleep Apnea Linked With Late-Life Epilepsy
Acne Treatment Differin Gel Approved for OTC Use
The once-daily acne treatment Differin Gel 0.1% (adapalene) has been approved for over-the counter use among people 12 and older, the U.S. Food and Drug Administration said.
It’s the first among a class of drugs called retinoids to be made available over the counter to treat acne. The drug’s active ingredient is the first new OTC acne treatment approved since the 1980s, the FDA said in a news release.
Differin Gel 0.1% was first approved in 1996 as a prescription drug.
Acne affects some 50 million people in the United States, mostly teens and young adults, the FDA said. Clusters of pimples most often form on the face, neck, back, chest and shoulders.
The agency warned that women who are pregnant, planning to become pregnant or breast feeding should get their doctor’s approval before using the product. While no specific issues with pregnant or breast-feeding women using Differin Gel have been identified, some retinoid drugs have been shown to cause birth defects, the FDA said.
Differin Gel 0.1% is distributed by Galderma Laboratories, based in Fort Worth, Tex.
More information
Visit Medline Plus to learn more about this drug.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.